Facility Manager / Sr. Manager (Contract)

About the Role

Reporting to the Senior Vice President, CMC, the contract Facility Manager will be responsible for the day-to-day management and operation of ALX Oncology’s South San Francisco office and laboratories. This role will oversee facility maintenance, workplace services, safety, security, permitting, vendors, and general office operations to ensure a safe, functional, and well-maintained workplace. The contract Facility Manager will work closely with employees, leadership, property management, vendors, landlords, local regulatory officials, and service providers and will collaborate cross-functionally with HR, IT, Finance, and Operations.

The ideal candidate is proactive, detail-oriented, service-minded, and comfortable working independently in a fast-paced, small-company environment.

Responsibilities

• Manage facility-related vendors, service providers, local regulatory officials, and property management relationships, including maintaining facility documentation, service records, contracts, permits, and compliance-related files.
• Oversee Environmental Health & Safety (EH&S) programs and workplace safety practices, including ALX staff training and supporting compliance with applicable federal, state, and local requirements.
• Coordinate office space planning, workstation setup, furniture moves, and related workplace projects, including office buildouts, relocations, and lab equipment moves and calibration.
• Ensure workplace services maintain conference rooms, common areas, kitchens, employee workspaces, and other shared spaces as functional, well-maintained, and appropriately stocked.
• Manage building access, security badge systems, and visitor procedures, including coordinating access, workspace setup, and equipment needs associated with employee onboarding and offboarding.
• Identify and implement opportunities to improve facility operations, workplace services, and operational efficiency.

Requirements

• Facilities, office operations, or workplace management experience, including responsibility for day-to-day building and workplace operations in a biotechnology or life sciences company.

Physical Demands

These demands are representative of the physical activities associated with the assignment:

• Regularly move throughout the office and building to oversee facility operations, inspect workspaces, and respond to workplace needs.
• Standing, walking, and sitting throughout the day, and using a computer for varying periods of time.
• Ability to bend, reach, stoop, and perform other physical activities associated with inspecting facilities, accessing equipment, and handling workplace supplies.
• Ability to safely use step stools or ladders as needed to access facility equipment, supplies, or building systems.
• Ability to occasionally lift and/or move up to 30 pounds and assist with moving office materials, supplies, or equipment as needed.

Schedule

• This is a 6 to 12-month contract assignment offering approximately 40 hours per week.
• Requires onsite presence at ALX’s South San Francisco office Monday – Wednesday, as well as availability to be onsite as needed during the remainder of the workweek, and on weekends to support facility needs.
• May need to be onsite before normal business hours or after employees have left for the day to coordinate facility activities and respond to operational needs.

Pay

The anticipated pay rate is approximately $50-$65 per hour, depending on skills and depth of experience.

About ALX Oncology

ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives. ALX Oncology’s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications. ALX Oncology’s second pipeline candidate, ALX2004, is a novel EGFR-targeted antibody-drug conjugate with a differentiated mechanism of action. A Phase 1, dose-escalation trial of ALX2004 is ongoing in patients with EGFR-expressing solid tumors. More information is available at www.alxoncology.com and on LinkedIn @ALXOncology.